Das PECom des Uterus – ein seltener mesenchymaler Tumor: Fallbericht und Literaturübersicht

Zusammenfassung

PECome des Uterus sind seltene mesenchymale Tumoren, ausgehend von perivaskulären, glattmuskulär differenzierten Zellen mit epitheloider Morphologie und immunhistochemischer Koexpression von glattmuskulären und melanozytären Markern. Mit einer Gesamtüberlebensrate von 92 % ist die Prognose gut und die Majorität der PECome ist als „low grade“-Läsion einzuordnen. Dennoch wird ein engmaschiges Follow-up empfohlen. Die Stadieneinteilung sollte nach Art der Leiomyosarkome erfolgen. Der vorliegende Fall wurde bei einer 65-jährigen Frau beobachtet mit einer maximalen Tumorgröße von 6 cm mit Infiltration adnexaler Mesostrukturen.

Abstract

Perivascular epithelioid cell tumor (PEComa) of the uterus is a rare mesenchymal lesion characterized by a proliferation of perivascular epitheloid cells with eosinophilic cytoplasm and immunohistochemical coexpression of both smooth muscle and melanocytic markers. The majority (∼ 92 %) of PEComas exhibit a benign behavior and are considered low-grade lesions. Nevertheless, a close follow-up of patients is necessary, and tumors should be staged like leiomyosarcomas. The presented case of a 65-year-old woman revealed a PEComa with diameter of 6 cm and adnexal involvement.

Tumor - Uterus - mesenchymaler Tumor - PEComa

perivascular epitheloid cell tumor - PEComa - uterus - mesenchymal tumor

Literatur

• 1 Abeler V M, Røyne O, Thoresen S et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.  Histopathology. 2009;  54 355-364
• 2 D'Angelo E, Prat J. Uterine sarcomas: A review.  Gynecol Oncol. 2010;  116 131-139
• 3 Köhler G. Klinik der uterinen Sarkome.  Onkologe. 2009;  30 304-312
• 4 Hendrickson M R, Tavassoli F A, Kempson R L et al. Mesenchymal Tumors of the Uterus and related Lesions.. Tavassoli F A, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and female genital Organs. World Health Organization Classification of Tumours.. Lyon: IARC Press; 2003: 233-249
• 5 Bonetti F, Pea M, Martignoni G et al. PEC and sugar.  Am J Surg Pathol. 1992;  16 307-308
• 6 Zamboni G, Pea M, Martignoni G et al. Clear cell “sugar” tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells.  Am J Surg Pathol. 1996;  20 722-730
• 7 Fukunaga M. Perivascular epithelioid cell tumor of the uterus: report of four cases.  Int J Gynecol Pathol. 2005;  24 341-346
• 8 Fadare O. Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases.  Adv Anat Pathol. 2008;  15 63-75
• 9 Folpe A L, Mentzel T, Lehr H A et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.  Am J Surg Pathol. 2005;  29 1558-1575
• 10 FIGO Committee on Gynecologic Oncology . FIGO staging for uterine sarcomas.  Int J Gynecol Obstet. 2009;  104 179
• 11 Horn L C, Schmidt D, Fathke C et al. New FIGO staging for uterine sarcomas.  Pathologe. 2009;  30 302-303
• 12 Pea M, Martignoni G, Zamboni G et al. Perivascular epithelioid cell.  Am J Surg Pathol. 1996;  20 1149-1153
• 13 Ramaiah S, Ganesan R, Mangham D C et al. Malignant variant of sclerosing perivascular epithelioid cell tumor arising in the adnexa.  Int J Gynecol Pathol. 2009;  28 589-593
• 14 Carvalho F M, Carvalho J P, Maluf F C et al. A new morphological variant of uterine PEComas with sex-cord-like pattern and WT1 expression: more doubts about the existence of uterine PEComas.  Ann Diagn Pathol. 2010;  14 129-132
• 15 Folpe A L, Goodman Z D, Ishak K G et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults.  Am J Surg Pathol. 2000;  24 1239-1246
• 16 Dimmler A, Seitz G, Hohenberger W et al. Late pulmonary metastasis in uterine PEComa.  J Clin Pathol. 2003;  56 627-628
• 17 Takeda T, Masuhara K, Kamiura S. Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.  Obstet Gynecol. 2008;  112 (2 Pt 2) 491-493
• 18 Bissler J J, McCormack F X, Young L R et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.  N Engl J Med. 2008;  358 140-145
• 19 Wolff N, Kabbani W, Bradley T et al. Sirolimus and temsirolimus for epithelioid angiomyolipoma.  J Clin Oncol. 2010;  28 e65-e68
• 20 Martignoni G, Pea M, Reghellin D et al. PEComas: the past, the present and the future.  Virchows Arch. 2008;  452 119-132